Nrc Health (NRC) EBITDA (2010 - 2026)

Nrc Health has disclosed EBITDA across 17 years of filings, most recently posting $5.6 million for Q1 2026.

• EBITDA for Q1 2026 came in at $5.6 million, down 35.21% year-over-year; the trailing twelve-month figure through Mar 2026 was $721000.0 (down 89.24% YoY), and the FY2025 annual result was $3.7 million, down 45.42% from the prior year.
• EBITDA came in at $5.6 million for Q1 2026 at Nrc Health, up from -$14.2 million in the prior quarter.
• In the past five years, EBITDA ranged from a high of $11.7 million in Q4 2023 to a low of -$25.3 million in Q4 2022.
• The 5-year median for EBITDA is $8.8 million (2024), against an average of $3.8 million.
• Across the five-year window, EBITDA tumbled 296.6% in 2022 and surged 146.26% in 2023, its largest moves.
• Nrc Health's EBITDA stood at -$25.3 million in 2022, then surged by 146.26% to $11.7 million in 2023, then slumped by 260.06% to -$18.7 million in 2024, then rose by 24.37% to -$14.2 million in 2025, then jumped by 139.29% to $5.6 million in 2026.
• The last three EBITDA figures came in at $5.6 million (Q1 2026), -$14.2 million (Q4 2025), and $7.7 million (Q3 2025), per Business Quant data.